The aim of the study was to explore the clinical value of serum human epididymis secretory
protein E4 (HE4) and CA125 in endometrial carcinoma. From January 2010 to April 2012 …

Background Endometrial cancer (EC) is a common female malignant cancer. The age of
incidence has become younger than before. If the diagnosis is during stage I, then the …

This study aims to investigate the correlation between preoperative human epididymis
protein 4 (HE4) levels, endometrial cancer (EC) staging, and ideal cutoff for stage prediction …

Background Human epididymis protein 4 (HE4) is a novel and specific biomarker for ovarian
cancer. The aim of this study is to evaluate a new tumor marker, HE4, in comparison with …

OBJECTIVE: To evaluate the prognostic value of pretherapeutic serum HE4 in endometrial
cancer in comparison to CA125. METHODS: HE4 and CA125 serum levels were analyzed …

OBJECTIVE: Human epididymal secretory protein E4 (HE4) is a new promising tumor
marker developed for the diagnostics and follow up of ovarian cancer. It has yet to become …

OBJECTIVE: Tumor markers with increased sensitivity and specificity for endometrial cancer
are needed to help monitor response to therapy and to detect recurrent disease. Currently …

Endometriosis is a gynaecological condition with an associated chronic inflammatory
response. The ectopic growth of 'lesions', consisting of endometrial cells outside the uterine …

Objective: To investigate the clinical significance of human epididymal secretory protein E4
(HE4) in combination with cancer antigen 125 (CA125) in the diagnosis of endometrial …

To date, no good marker for endometrial cancer (EC) that may be routinely used in clinical
practice for diagnosis, prognosis and monitoring is available; besides the use of tumour …